Comparison of Drug Prescribing Before and During the COVID-19 Pandemic - A Cross-national European Study. Pharmaceuticals Consumption data
Creators
- 1. Department of Medical Biophysics, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic
- 2. AOK Research Institute (WIdO), Berlin, Germany
- 3. Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK; Public Health Scotland, Edinburgh, UK
- 4. Department of Pharmacy, Uppsala University, Uppsala, Sweden
- 5. School of Public Health and Community Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden
- 6. Health Insurance Institute of Slovenia, Ljubljana, Slovenia
- 7. Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine,Vilnius University, Vilnius, Lithuania
- 8. State Institute for Drug Control, Praha, Czech Republic
- 9. Drug Department, Catalan Health Service, Barcelona, Spain
- 10. Public Health Scotland, Edinburgh, UK
- 11. Drug Department, Catalan Health Service, Barcelona, Spain; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain
- 12. Department of Pharmacy, Uppsala University, Uppsala, Sweden; Pharmacy Center, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
Description
Data and code supporting the article (currently under review):
Comparison of Drug Prescribing Before and During the COVID-19 Pandemic - A Cross-national European Study
Prescription data from January 2017 to March 2021 for the Czech Republic, Germany, Lithuania, Slovenia, Spain (Catalonia), Sweden, and the United Kingdom (Scotland).
Data include the codes of the Anatomical-Therapeutic-Chemical classification (ATC) and corresponding numbers of dispensed defined daily doses (DDDs) and packs, aggregated by country, month and ATC.
For more information, see the accompanying document ReadMe.txt.